PP2‐mediated Pyk2 phosphorylation inhibition has been shown to efficiently reverse fibrosis development in a load‐induced cardiac hypertrophy mouse model 52 and to attenuate fibrosis after MI 53. This evidence concerns the gene PTK2B and cardiac hypertrophy.